McKesson Co. (NYSE:MCK) Stock Holdings Lifted by Mediolanum International Funds Ltd

Mediolanum International Funds Ltd lifted its holdings in McKesson Co. (NYSE:MCK) by 7.1% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 40,645 shares of the company’s stock after buying an additional 2,689 shares during the quarter. Mediolanum International Funds Ltd’s holdings in McKesson were worth $19,812,000 as of its most recent filing with the SEC.

Other large investors also recently modified their holdings of the company. Distillate Capital Partners LLC lifted its position in shares of McKesson by 127,542.9% in the 2nd quarter. Distillate Capital Partners LLC now owns 35,740 shares of the company’s stock worth $20,874,000 after buying an additional 35,712 shares during the last quarter. Chase Investment Counsel Corp lifted its position in shares of McKesson by 50.8% in the 2nd quarter. Chase Investment Counsel Corp now owns 8,985 shares of the company’s stock worth $5,247,000 after buying an additional 3,027 shares during the last quarter. Wealthspire Advisors LLC lifted its position in shares of McKesson by 8.9% in the 2nd quarter. Wealthspire Advisors LLC now owns 1,623 shares of the company’s stock worth $948,000 after buying an additional 133 shares during the last quarter. Councilmark Asset Management LLC bought a new position in shares of McKesson in the 1st quarter worth about $5,160,000. Finally, Vaughan David Investments LLC IL bought a new position in shares of McKesson in the 2nd quarter worth about $238,000. 85.07% of the stock is currently owned by institutional investors.

Insider Buying and Selling at McKesson

In related news, CEO Brian S. Tyler sold 3,753 shares of the company’s stock in a transaction dated Thursday, September 5th. The stock was sold at an average price of $561.10, for a total value of $2,105,808.30. Following the completion of the sale, the chief executive officer now owns 78,586 shares in the company, valued at approximately $44,094,604.60. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Corporate insiders own 0.11% of the company’s stock.

McKesson Trading Up 0.4 %

NYSE MCK traded up $2.04 during trading on Friday, reaching $507.00. 95,225 shares of the company’s stock were exchanged, compared to its average volume of 801,036. McKesson Co. has a fifty-two week low of $431.35 and a fifty-two week high of $637.51. The firm has a market capitalization of $65.88 billion, a PE ratio of 22.56, a P/E/G ratio of 1.17 and a beta of 0.44. The company’s fifty day simple moving average is $518.29 and its 200-day simple moving average is $551.37.

McKesson (NYSE:MCK) last announced its quarterly earnings data on Wednesday, August 7th. The company reported $7.88 EPS for the quarter, topping analysts’ consensus estimates of $7.21 by $0.67. McKesson had a negative return on equity of 242.57% and a net margin of 0.94%. The firm had revenue of $79.28 billion during the quarter, compared to analyst estimates of $82.53 billion. During the same period last year, the company posted $7.27 EPS. The business’s quarterly revenue was up 6.4% compared to the same quarter last year. Equities analysts forecast that McKesson Co. will post 32.07 EPS for the current fiscal year.

McKesson Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, October 1st. Shareholders of record on Monday, September 2nd were given a $0.71 dividend. This is an increase from McKesson’s previous quarterly dividend of $0.62. The ex-dividend date of this dividend was Friday, August 30th. This represents a $2.84 annualized dividend and a yield of 0.56%. McKesson’s payout ratio is presently 12.69%.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. Robert W. Baird reaffirmed a “neutral” rating and issued a $531.00 price objective (down previously from $603.00) on shares of McKesson in a report on Tuesday, September 24th. Leerink Partners dropped their price objective on shares of McKesson from $665.00 to $630.00 and set an “outperform” rating on the stock in a report on Monday, October 7th. Baird R W cut shares of McKesson from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 24th. Mizuho raised their target price on shares of McKesson from $540.00 to $570.00 and gave the company a “neutral” rating in a research note on Thursday, August 8th. Finally, Deutsche Bank Aktiengesellschaft dropped their price target on McKesson from $623.00 to $579.00 and set a “buy” rating on the stock in a report on Wednesday, September 25th. Five research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to MarketBeat.com, McKesson presently has a consensus rating of “Moderate Buy” and a consensus price target of $610.86.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.